Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: A 15-year follow-up of NIPPON DATA90

被引:12
作者
Kadota, Aya [1 ,2 ]
Miura, Katsuyuki [1 ]
Okamura, Tomonori [3 ]
Hozawa, Atsushi [4 ]
Murakami, Yoshitaka [1 ]
Fujiyoshi, Akira [1 ]
Takashima, Naoyuki [1 ]
Hayakawa, Takehito [5 ]
Kita, Yoshikuni [1 ]
Okayama, Akira [6 ]
Nakamura, Yasuyuki [7 ]
Ueshima, Hirotsugu [1 ]
机构
[1] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 5202192, Japan
[3] Keio Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan
[4] Yamagata Univ, Grad Sch Med, Dept Publ Hlth, Yamagata 990, Japan
[5] Fukushima Med Univ, Dept Hyg & Prevent Med, Fukushima, Japan
[6] Japan AntiTB Assoc, Inst Hlth Serv 1, Tokyo, Japan
[7] Kyoto Womens Univ, Kyoto, Japan
关键词
Metabolic risk factor; Cardiovascular disease; Mortality; Epidemiology; HEART-DISEASE; ALL-CAUSE; INSULIN-RESISTANCE; BLOOD-PRESSURE; GLUCOSE; OBESITY; CHOLESTEROL; DEFINITION; DEATH;
D O I
10.1016/j.atherosclerosis.2010.11.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The individual components of metabolic syndrome are defined as levels ranging from moderate to high level as to require medication. We investigated the impact of moderate metabolic risk factor clustering on cardiovascular disease (CVD) mortality. Methods: We followed up 6758 non-lean Japanese in randomly selected areas from all over the country who had no history of CVD for 15 years. The multivariate-adjusted hazards ratio (HR) and 95% confidence interval (CI) for CVD mortality according to the number of moderate metabolic risk factors (BMI >= 25 kg/m(2), 130/85mmHg <= systolic/diastolic BP < 140/90mmHg, 140 mg/dl <= casual blood glucose < 200 mg/dl, triglycerides > 150 mg/dl and/or HDL cholesterol < 40 mg/dl [men], 50 mg/dl [women]) were estimated using the Cox proportional hazards model. The population-attributable risk fraction of moderate metabolic risk factor clustering was also estimated. Results: During the follow-up, 282 participants died of CVD. CVD mortality tended to increase with the number of moderate metabolic risk factors. However, they were not statistically significant. The multivariate-adjusted HRs were 1.82 (95% CI: 0.89-3.73) for having any moderate metabolic risk factors and 2.87 (95% CI: 1.46-5.64) for having any medication-required metabolic risk factors, compared with participants without any moderate metabolic risk factors. The population-attributable risk fractions were 7.3% and 52.4% for any moderate and medication-required metabolic risk factors, respectively. Conclusions: We did not find the statistically significant increase of CVD mortality for moderate metabolic risk factor clustering. Its attribution was relatively small in this Japanese population. More efforts would be required to detect and control medication-required risk factors. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 32 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
American Diabetes Association, 2009, DIABETES CARE, V29, pS43
[5]  
CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[8]   Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence [J].
Ford, ES .
DIABETES CARE, 2005, 28 (07) :1769-1778
[9]   CONTRIBUTION OF INTRAABDOMINAL FAT ACCUMULATION TO THE IMPAIRMENT OF GLUCOSE AND LIPID-METABOLISM IN HUMAN OBESITY [J].
FUJIOKA, S ;
MATSUZAWA, Y ;
TOKUNAGA, K ;
TARUI, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1987, 36 (01) :54-59
[10]   Major risk factors as antecedents of fatal and nonfatal coronary heart disease events [J].
Greenland, P ;
Knoll, MD ;
Stamler, J ;
Neaton, JD ;
Dyer, AR ;
Garside, DB ;
Wilson, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :891-897